Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo Nordisk

CureVac announces resolution of patent litigation with Pfizer/BioNTech

Written By Ruchika Sharma8 Aug 2025 5:30 PM IST

CureVac N.V., a multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), has announced that...

Marksans Pharma Gets USFDA Nod for Generic Tessalon Capsules

Marksans Pharma gets USFDA nod for heartburn drug

Written By Ruchika Sharma8 Aug 2025 12:10 PM IST

Mumbai: Marksans Pharma Limited's wholly owned subsidiary, Marksans Pharma Inc., has received final approval from the U.S. Food and...

Zydus Lifesciences gets NOC from Health Canada for ZDS-Varenicline tablets

Written By Ruchika Sharma8 Aug 2025 10:00 AM IST

Ahmedabad: Zydus Lifesciences Limited has received NOC (Notice of Compliance) from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg. This...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Teva Pharma announces USFDA filing acceptance for Ajovy in Pediatric Episodic Migraine prevention

Written By Ruchika Sharma6 Aug 2025 12:38 PM IST

Parsippany: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced that the U.S. Food and Drug...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Sanofi completes acquisition of Vigil Neuroscience

Written By Ruchika Sharma6 Aug 2025 11:30 AM IST

Paris: Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. This acquisition strengthens Sanofi's early-stage pipeline...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

Bristol Myers Squibb Breyanzi application accepted for priority review by USFDA for Marginal Zone Lymphoma

Written By Ruchika Sharma5 Aug 2025 12:20 PM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental biologics license...

Cipla Bommasandra facility gets VAI classification from USFDA

Written By Ruchika Sharma5 Aug 2025 11:54 AM IST

Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the current Good Manufacturing Practices (cGMP)...

Cipla, Hetero win bid to supply widely prescribed diabetes drug in China

Over 5 lakh Tramadol, Alprazolam tablets worth Rs 20 crore seized,; 5 arrested

Written By Ruchika Sharma4 Aug 2025 1:21 PM IST

New Delhi: The Narcotics Control Bureau (NCB) has uncovered a syndicate involved in illegally diverting pharma drugs across Uttar Pradesh and...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche Susvimo maintains vision over five years with two refills per year in people with nAMD

Written By Ruchika Sharma4 Aug 2025 12:30 PM IST

Basel: Roche has announced new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the...

Indias landmark Dengue Vaccine trial enrolment to wrap up by October: ICMR

One-shot Dengue vaccine 'DengiAll' completes 70% enrolment of participants in Phase III trial: Centre

Written By Ruchika Sharma3 Aug 2025 2:45 PM IST

New Delhi: Seventy per cent of participant enrolment has been completed for the Phase III clinical trial of indigenous one-shot dengue vaccine,...

Torrent Pharma Slapped with Rs 41.33 Crore GST Penalty for Alleged Erroneous Export Refunds

Torrent Pharma: USFDA concludes inspection at Vizag facility with zero observations

Written By Ruchika Sharma2 Aug 2025 3:38 PM IST

Ahmedabad: Torrent Pharma has announced that the U.S. Food and Drug Administration (USFDA) has concluded an inspection at the company's...

Gilead Sciences gets USFDA nod for new Biktarvy indication for people with HIV who are treatment experienced, restarting antiretroviral treatment

Written By Ruchika Sharma2 Aug 2025 12:30 PM IST

Foster City: Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok